LeMaitre to Participate at Upcoming Investor Conferences in November
LeMaitre Vascular (Nasdaq:LMAT) has announced its participation in three major investor conferences this November. David Roberts, President, will present at the UBS Global Healthcare Conference in Rancho Palos Verdes on November 13 at 7:15 AM PT, Stifel's Healthcare Conference in New York City on November 19 at 1:50 PM ET, and the Wolfe Research Healthcare Conference in New York City on November 20 at 2:00 PM ET.
LeMaitre specializes in devices and implants for peripheral vascular disease treatment, serving over 200 million affected patients worldwide. The company focuses on developing and manufacturing vascular devices for surgeons, offering a diverse portfolio of branded products for arteries and veins outside the heart.
LeMaitre Vascular (Nasdaq:LMAT) ha annunciato la sua partecipazione a tre importanti conferenze per investitori questo novembre. David Roberts, Presidente, presenterà alla UBS Global Healthcare Conference a Rancho Palos Verdes il 13 novembre alle 7:15 AM PT, alla Stifel's Healthcare Conference a New York il 19 novembre alle 1:50 PM ET e alla Wolfe Research Healthcare Conference a New York il 20 novembre alle 2:00 PM ET.
LeMaitre si specializza in dispositivi e impianti per il trattamento delle malattie vascolari periferiche, servendo oltre 200 milioni di pazienti colpiti in tutto il mondo. L'azienda si concentra sullo sviluppo e sulla produzione di dispositivi vascolari per chirurghi, offrendo un portafoglio diversificato di prodotti a marchio per arterie e vene al di fuori del cuore.
LeMaitre Vascular (Nasdaq:LMAT) ha anunciado su participación en tres importantes conferencias para inversores este noviembre. David Roberts, Presidente, presentará en la UBS Global Healthcare Conference en Rancho Palos Verdes el 13 de noviembre a las 7:15 AM PT, en la Stifel's Healthcare Conference en la ciudad de Nueva York el 19 de noviembre a la 1:50 PM ET, y en la Wolfe Research Healthcare Conference en la ciudad de Nueva York el 20 de noviembre a las 2:00 PM ET.
LeMaitre se especializa en dispositivos e implantes para el tratamiento de enfermedades vasculares periféricas, atendiendo a más de 200 millones de pacientes afectados en todo el mundo. La empresa se centra en el desarrollo y fabricación de dispositivos vasculares para cirujanos, ofreciendo un portfolio diverso de productos de marca para arterias y venas fuera del corazón.
LeMaitre Vascular (Nasdaq:LMAT)는 이번 11월 세 가지 주요 투자자 회의에 참가할 것이라고 발표했습니다. David Roberts 사장은 13일 오전 7시 15분 PT에 Rancho Palos Verdes에서 개최되는 UBS Global Healthcare Conference에서 발표하고, 19일 오후 1시 50분 ET에 뉴욕에서 개최되는 Stifel's Healthcare Conference와 20일 오후 2시 ET에 뉴욕에서 열리는 Wolfe Research Healthcare Conference에서 발표할 예정입니다.
LeMaitre는 말초 혈관 질환 치료를 위한 장치 및 임플란트를 전문으로 하며, 전 세계적으로 2억 명 이상의 영향을 받은 환자들을 돕고 있습니다. 이 회사는 외과의를 위한 혈관 장치의 개발 및 제조에 집중하고 있으며, 심장 외부의 동맥 및 정맥을 위한 다양한 브랜드 제품 포트폴리오를 제공합니다.
LeMaitre Vascular (Nasdaq:LMAT) a annoncé sa participation à trois grandes conférences pour investisseurs ce novembre. David Roberts, Président, fera une présentation à la UBS Global Healthcare Conference à Rancho Palos Verdes le 13 novembre à 7h15 PT, à la Stifel's Healthcare Conference à New York le 19 novembre à 13h50 ET et à la Wolfe Research Healthcare Conference à New York le 20 novembre à 14h00 ET.
LeMaitre se spécialise dans les dispositifs et implants pour le traitement des maladies vasculaires périphériques, servant plus de 200 millions de patients touchés dans le monde. L'entreprise se concentre sur le développement et la fabrication de dispositifs vasculaires pour les chirurgiens, offrant un portefeuille diversifié de produits de marque pour les artères et veines en dehors du cœur.
LeMaitre Vascular (Nasdaq:LMAT) hat seine Teilnahme an drei wichtigen Investorenkonferenzen in diesem November angekündigt. David Roberts, Präsident, wird am 13. November um 7:15 Uhr PT auf der UBS Global Healthcare Conference in Rancho Palos Verdes, am 19. November um 13:50 Uhr ET auf der Stifel's Healthcare Conference in New York City und am 20. November um 14:00 Uhr ET auf der Wolfe Research Healthcare Conference in New York City präsentieren.
LeMaitre spezialisiert sich auf Geräte und Implantate zur Behandlung von peripheren Gefäßerkrankungen und bedient weltweit über 200 Millionen betroffene Patienten. Das Unternehmen konzentriert sich auf die Entwicklung und Herstellung von Gefäßgeräten für Chirurgen und bietet ein vielfältiges Portfolio an Markenprodukten für Arterien und Venen außerhalb des Herzens an.
- None.
- None.
BURLINGTON, Mass., Nov. 01, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in three upcoming investor conferences in November.
UBS Global Healthcare Conference
Wednesday, November 13, 2024
Terranea Resort, Rancho Palos Verdes, CA
David Roberts, President, will present at 7:15 AM PT
Stifel's 2024 Healthcare Conference
Tuesday, November 19, 2024
Lotte NY Palace Hotel, New York City
David Roberts, President, will present at 1:50 PM ET
Wolfe Research Healthcare Conference 2024
Wednesday, November 20, 2024
Wolfe Research HQ, New York City
David Roberts, President, will present at 2:00 PM ET
About LeMaitre
LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. The Company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. Additional information can be found at www.lemaitre.com.
FAQ
When is LeMaitre (LMAT) presenting at the UBS Global Healthcare Conference 2024?
Which investor conferences is LeMaitre (LMAT) attending in November 2024?
How many patients are affected by peripheral vascular disease that LeMaitre (LMAT) treats?
Who will be presenting at the November 2024 investor conferences for LeMaitre (LMAT)?
